Covered recipient · General Payments record
UMA N SRIVATSA
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$17,405.15
- Reported across 94 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $2,471.09 | 9 |
| Food and Beverage | $308.23 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $2,711.27 | 13 |
| BOSTON SCIENTIFIC CORPORATION | $28.82 | 1 |
| Abbott Laboratories | $21.18 | 1 |
| Recor Medical Inc | $18.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.18 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125145313 | CMS |
| Boston Scientific Corporation | $28.82 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092739570 | CMS |
| Medtronic, Inc. | $948.66 | 07/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119394108 | CMS |
| Medtronic, Inc. | $732.63 | 07/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119394132 | CMS |
| Medtronic, Inc. | $239.00 | 07/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119394128 | CMS |
| Medtronic, Inc. | $27.54 | 07/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119394130 | CMS |
| Medtronic, Inc. | $9.53 | 07/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119394110 | CMS |
| Medtronic, Inc. | $47.68 | 07/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119394112 | CMS |
| Medtronic, Inc. | $44.22 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119394116 | CMS |
| Medtronic, Inc. | $389.48 | 07/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119394118 | CMS |
| Medtronic, Inc. | $61.57 | 07/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119394120 | CMS |
| Medtronic, Inc. | $15.00 | 07/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119394114 | CMS |
| Medtronic, Inc. | $96.74 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119394122 | CMS |
| Medtronic, Inc. | $52.97 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119394124 | CMS |
| Medtronic, Inc. | $46.25 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119394126 | CMS |
| Recor Medical Inc | $18.05 | 07/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127686168 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.